A Sydney-based global leader in hearing implants has become the latest blue-chip company to suffer whiplash after missing profit forecasts during the nation's increasingly volatile earnings season.
Cochlear shares plunged 18.9 per cent to a more than three-year low of $199.22 on Friday after the company trimmed its guidance because its next-generation implant took longer to roll out than anticipated.
